UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma

Annals of oncology, 2024-09

2024

Volltextzugriff (PDF)

Dynamics of the monoclonal antibodies (MABs) treatment rate and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia from 2013 to 2016

Annals of oncology, 2018-06, Vol.29, p.v76-v76

2018

Volltextzugriff (PDF)

Surgical and combined treatment for patients with cholangiocarcinoma: the experience of FSBI

Annals of oncology, 2019-07, Vol.30, p.iv4-iv4

2019

Volltextzugriff (PDF)

Prognostic factors of chemo-radiotherapy efficacy in patients with locally-advanced rectal cancer

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii169

2018

Volltextzugriff (PDF)

A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy

Annals of oncology, 2010-09, Vol.21 (9), p.1779-1785

2010

Volltextzugriff (PDF)

Association between duration of oxaliplatin-free interval and effect of reintroduction of oxaliplatin-containing chemotherapy in patients with metastatic colorectal cancer (mCRC)

Annals of oncology, 2018-06, Vol.29, p.v76-v76

2018

Volltextzugriff (PDF)

Gut Microbiome as a Predictor of the Anti-PD-1 Therapy Success: Metagenomic Data Analysis

Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry, 2021-04, Vol.15 (2), p.161-165

2021

Volltextzugriff (PDF)

P-410 Factors affecting progression-free survival (PFS) for patients with metastatic colorectal cancer (mCRC) receiving regorafenib or for patients after re-challenge previously effective chemotherapy (CT) regimens in third or following lines

Annals of oncology, 2023-06, Vol.34, p.S156-S156

2023

Volltextzugriff (PDF)

Interdisciplinary approach to the management of patients with uterine cancer progression

Opukholi zhenskoĭ reproduktivnoĭ sistemy, 2022-05, Vol.18 (1), p.87-96

2022

Volltextzugriff (PDF)

Olaparib maintenance therapy after frontline chemotherapy in patients with BRCA-mutated ovarian cancer: real-world results in expanded access program

Medicinskij sovet, 2022-06 (9), p.77-83

2022

Volltextzugriff (PDF)

Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer

Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia, 2020-11, Vol.22 (3), p.127-132

2020

Volltextzugriff (PDF)

541P Efficacy of various anticancer agents after failure of maintenance olaparib: A retrospective study

Annals of oncology, 2022-09, Vol.33, p.S794-S795

2022

Volltextzugriff (PDF)

FOLFOXIRI versus FOLFOX or FOLFIRI with targeted therapy in patients with mutant BRAF metastatic colorectal cancer: A systematic review and meta-analysis

Medicinskij sovet, 2020-12 (20), p.125-132

2020

Volltextzugriff (PDF)

Modern aspects of antiangiogenic therapy in ovarian cancer

Medical Council, 2018-11 (19), p.17-21

2018

Volltextzugriff (PDF)

Results of combined nivolumab and ipilimumab therapy in patients with cancer

Medicinskij sovet, 2021-12 (20), p.18-23

2021

Volltextzugriff (PDF)

Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment

Hirurgija (Moskva), 2018 (12), p.30

2018

Volltextzugriff (PDF)

2099P The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis

Annals of oncology, 2023-10, Vol.34, p.S1101-S1101

2023

Volltextzugriff (PDF)

P-333 Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer

Annals of oncology, 2023-06, Vol.34, p.S131-S131

2023

Volltextzugriff (PDF)

P-271 Meta-analyses on mutation status concordance between tumor tissue and circulating tumor DNA and prognostic value of ctDNA in pancreatic cancer

Annals of oncology, 2020-07, Vol.31, p.S178

2020

Volltextzugriff (PDF)

Impact of СD8/FoxP3 T lymphocyte ratio in the peritumoral area of primary cutaneous melanoma on the prognosis of the disease

Arkhiv patologii, 2016-07, Vol.78 (4), p.27

2016

Volltextzugriff (PDF)

Molecular portrait of stomach cancer associated with the Epstein–Barr virus

Uspehi molekulârnoj onkologii, 2020-11, Vol.7 (3), p.27-36

2020

Volltextzugriff (PDF)

A PARADIGM SHIFT IN THE TREATMENT OF PATIENTS WITH RESECTABLE PANCREATIC CANCER

Sibirskiĭ onkologicheskiĭ zhurnal, 2020-07, Vol.19 (3), p.156-163

2020

Volltextzugriff (PDF)

COMBINATION CHEMOTHERAPY REGIMENS IN PANCREATIC CANCER

Medical Council, 2017-06 (6), p.62-70

2017

Volltextzugriff (PDF)

601TiP A multicenter randomized clinical trial evaluating the negative hyperselection of patients with RAS/BRAF wild-type metastatic colorectal cancer who are eligible for anti-EGFR therapy

Annals of oncology, 2024-09, Vol.35, p.S481-S481

2024

Volltextzugriff (PDF)

780P Propensity-score matching analysis for efficacy of platinum-based versus non-platinum chemotherapy in patients with “platinum-resistant” ovarian cancer (PROC): Real-world recent cohort study

Annals of oncology, 2024-09, Vol.35, p.S586-S586

2024

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(168)
Tagungsberichte
(10)

Sprache

Englisch
(169)
Russisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma

Dynamics of the monoclonal antibodies (MABs) treatment rate and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia from 2013 to 2016

Surgical and combined treatment for patients with cholangiocarcinoma: the experience of FSBI

Prognostic factors of chemo-radiotherapy efficacy in patients with locally-advanced rectal cancer

A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy

Association between duration of oxaliplatin-free interval and effect of reintroduction of oxaliplatin-containing chemotherapy in patients with metastatic colorectal cancer (mCRC)

Gut Microbiome as a Predictor of the Anti-PD-1 Therapy Success: Metagenomic Data Analysis

P-410 Factors affecting progression-free survival (PFS) for patients with metastatic colorectal cancer (mCRC) receiving regorafenib or for patients after re-challenge previously effective chemotherapy (CT) regimens in third or following lines

Interdisciplinary approach to the management of patients with uterine cancer progression

Olaparib maintenance therapy after frontline chemotherapy in patients with BRCA-mutated ovarian cancer: real-world results in expanded access program

Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer

541P Efficacy of various anticancer agents after failure of maintenance olaparib: A retrospective study

FOLFOXIRI versus FOLFOX or FOLFIRI with targeted therapy in patients with mutant BRAF metastatic colorectal cancer: A systematic review and meta-analysis

Modern aspects of antiangiogenic therapy in ovarian cancer

Results of combined nivolumab and ipilimumab therapy in patients with cancer

Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment

2099P The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis

P-333 Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer

P-271 Meta-analyses on mutation status concordance between tumor tissue and circulating tumor DNA and prognostic value of ctDNA in pancreatic cancer

Impact of СD8/FoxP3 T lymphocyte ratio in the peritumoral area of primary cutaneous melanoma on the prognosis of the disease

Molecular portrait of stomach cancer associated with the Epstein–Barr virus

A PARADIGM SHIFT IN THE TREATMENT OF PATIENTS WITH RESECTABLE PANCREATIC CANCER

COMBINATION CHEMOTHERAPY REGIMENS IN PANCREATIC CANCER

601TiP A multicenter randomized clinical trial evaluating the negative hyperselection of patients with RAS/BRAF wild-type metastatic colorectal cancer who are eligible for anti-EGFR therapy

780P Propensity-score matching analysis for efficacy of platinum-based versus non-platinum chemotherapy in patients with “platinum-resistant” ovarian cancer (PROC): Real-world recent cohort study

Suchergebnisse filtern